Back to Journals » Drug Design, Development and Therapy » Volume 12
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
CTL019 (tisagenlecleucel): CAR-T therapy for relapsed and refractory B-cell acute lymphoblastic leukemia
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
40,732 | Dovepress* | 20,274+ | 2,588 | 22,862 | |
PubMed Central* | 20,458 | 3,146 | 23,604 | ||
Totals | 40,732 | 5,734 | 46,466 | ||
*Since 12 November 2018 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
11 | 1 | 0 | 0 | 1 | 9 |
View citations on PubMed Central and Google Scholar